SoMCC Event

Overview: 
The development and application of existing and emerging tools for molecular analysis are revolutionizing our ability to interrogate experimental and patient samples in pursuit of biomedical discoveries and patient diagnoses.  This explosion of genetic information is happening at the same time we are just discovering new classes of genome structures such as miRNAs and enumerating them.  At the same time we are just beginning to understand the function of well known and enumerated structures such as genes and common polymorphisms.  It is as if we had access to modern imaging systems such as positron emission tomography while our knowledge of human anatomy and physiology was in its Aristotelian state. 

This seminar offers a unique opportunity to hear, from a biotechnology company perspective, about the parallel developments in science and technology that are allowing us to exponentially increase of our understanding of the structure and function of the genome and to hear directly from a scientist who is one of Affymetrix’ executives.
                                                                                                  
About the Speaker:
Robert Lipshutz leads Affymetrix’ Corporate Development team where he is responsible for implementing the companies product plan and strategic vision through partnerships with other companies and other business combinations.  Lipshutz joined Affymetrix as Director of Bioinformatics and has held positions as Director of Advanced Technology, Vice President of Business Development and Licensing, and Senior Vice President of Molecular Diagnostics and Emerging Markets where he developed and implemented Affymetrix’ diagnostic partnering strategy.

Lipshutz received his A.B. and Ph.D. in Mathematics from Harvard University and UC Berkeley respectively.